IMPORTANT NOTE: You may submit your article only through our online submission systemSubmit your manuscript
  • Slider Image

Reviews 2005-2018

Therapeutic Innovations for Targeting Childhood Neuroblastoma: Implications of the Neurokinin-1 Receptor System. M. BERGER, D. VON SCHWEINITZ (Munich, Germany). Anticancer Res 37:5911-5918, 2017.
Fluoride Induces Apoptosis in Mammalian Cells: In Vitro and In Vivo Studies. D.A. RIBEIRO, C.M. CARDOSO, V.Q. YUJRA, M.D.B. VIANA, O. AGUIAR JR, L.P. PISANI, C.T.F. OSHIMA (Sao Paulo, Brazil). Anticancer Res 37:4767-4778, 2017.
Colorectal Carcinogenesis: Role of Oxidative Stress and Antioxidants. F. CARINI, M. MAZZOLA, F. RAPPA, A. JURJUS, A.G. GEAGEA, S. AL KATTAR, T. BOU-ASSI, R. JURJUS, P. DAMIANI, A. LEONE, G. TOMASELLO (Palermo, Italy; Beirut; Jal El Dib, Lebanon; Washington, DC, USA). Anticancer Res 37:4759-4766, 2017.
Deepening a Simple Question: Can MSCs Be Used to Treat Cancer? J.P.A. GOMES, A.F. ASSONI, M. PELATTI, G. COATTI, O.K. OKAMOTO, M. ZATZ (Sao Paulo, Brazil). Anticancer Res 37:4747-4758, 2017.
Physical Needs of Long-term Cancer Patients. P. TRALONGO, M.G. PESCARENICO, A. SURBONE, S. BORDONARO, M. BERRETTA, A. DI MARI (Syracuse; Parma; Aviano, Italy; New York, NY, USA). Anticancer Res 37:4733-4746, 2017.
Lidocaine Stimulates the Function of Natural Killer Cells in Different Experimental Settings. J.P. CATA, M.F. RAMIREZ, J.F. VELASQUEZ, A. DI, K.U. POPAT, V. GOTTUMUKKALA, D.M. BLACK, V.O. LEWIS, J.N. VAUTHEY (Houston; Temple, TX; Boston, MA, U.S.A.; Medellin, Colombia). Anticancer Res 37:4727-4732, 2017.
Thrombocytosis Portends Adverse Prognosis in Colorectal Cancer: A Meta-Analysis of 5,619 Patients in 16 Individual Studies. D. GU, A. SZALLASI (Livingston, NJ; Jacksonville, FL, USA). Anticancer Res 37:4717-4726, 2017.
Impact of Parental Cancer on Children. B.K. SHAH, J. ARMALY, E. SWIETER (Sedro-Woolley; Yakima, WA, USA). Anticancer Res 37:4025-4028, 2017.
Genotoxicity Induced by Dental Materials: A Comprehensive Review. D.A. RIBEIRO, V.Q. YUJRA, C.F.G. DE MOURA, B.A. HANDAN, M.D.B. VIANA, L.Y. YAMAUCHI, P.M. CASTELO, O. AGUIAR JR (Sao Paolo, Brazil). Anticancer Res 37:4017-4024, 2017.
Lower Body Lymphedema in Patients with Gynecologic Cancer. N. BIGLIA, V. ZANFAGNIN, A. DANIELE, E. ROBBA, V.E. BOUNOUS (Turin, Italy). Anticancer Res 37:4005-4016, 2017.
Vitamin D Receptor Polymorphism and Cancer: An Update. V. RAI, J. ABDO, S. AGRAWAL, D.K. AGRAWAL (Omaha, NE, USA). Anticancer Res 37:3991-4004, 2017.
BDNF: An Oncogene or Tumor Suppressor? D.P. RADIN, P. PATEL (Stony Brook; New York City, NY, USA). Anticancer Res 37:3983-3990, 2017.
Clinicopathological and Corresponding Genetic Features of Colorectal Signet Ring Cell Carcinoma. K. TAJIRI, T. SUDOU, F. FUJITA, T. HISAKA, T. KINUGASA, Y. AKAGI (Fukuoka, Japan). Anticancer Res 37:3817-3824, 2017.
Clinical Implications of Augmenter of Liver Regeneration in Cancer: A Systematic Review. K.H. NGUYEN, A.H. NGUYEN, D.V. DABIR (Los Angeles, CA, USA). Anticancer Res 37:3379-3384, 2017.
Application of Cancer Cell Reprogramming Technology to Human Cancer Research.  X.-Y. PAN, M.-H. TSAI, K. WUPUTRA, C.-C. KU, W.-H. LIN, Y.-C. LIN, S. KISHIKAWA, M. NOGUCHI, S. SAITO, C.-S. LIN, K.K. YOKOYAMA (Hanzhou, PR China; Kaohsiung, Taiwan, ROC; Tsukuba; Yaita; Tokyo; Sanuki, Japan). Anticancer Res 37:3367-3378, 2017.
Desmoid Tumors in Familial Adenomatous Polyposis. M.L. DE MARCHIS, F. TONELLI, D. QUARESMINI, D. LOVERO, D. DELLA-MORTE, F. SILVESTRIS, F. GUADAGNI, R. PALMIROTTA (Rome; Florence; Bari, Italy). Anticancer Res 37:3357-3366, 2017.
Measuring Intragastric Tumor Markers in Gastric Cancer Patients: a Systematic Literature Review on Significance and Reliability. E. VIRGILIO, A. PROIETTI, R. D’URSO, P. CARDELLI, E. GIARNIERI, M. MONTAGNINI, M.R. GIOVAGNOLI, P. MERCANTINI, G. BALDUCCI, M. CAVALLINI (Rome, Italy). Anticancer Res 37:2817-2822,2017.
Targeted Therapy in Ovarian Cancer. A Comprehensive Systematic Review of Literature. Y. DIAB, M.Z. MUALLEM (Victoria, Australia; Berlin, Germany). Anticancer Res 37:2809-2816,2017.
Cancer Tissue Classification, Associated Therapeutic Implications and PDT as an Alternative. T.K. HORNE, M.J. CRONJE (Johannesburg, South Africa). Anticancer Res 37:2785-2808,2017.
Erdheim–Chester Disease: Comprehensive Review of Molecular Profiling and Therapeutic Advances. F. HAROUN, K. MILLADO, I. TABBARA (Washington, DC, USA). Anticancer Res 37:2777-2784,2017.
Pancreatic Cancer Stem Cells and Therapeutic Approaches. G. ERCAN, A. KARLITEPE, B. OZPOLAT (Izmir, Turkey; Houston, TX, USA). Anticancer Res 37:2761-2776,2017.
68Ga-PSMA-PET/CT Ηas a Role in Detecting Prostate Cancer Lesions in Patients with Recurrent Disease. C. FITZPATRICK, O. LYNCH, L. MARIGNOL (Dublin, Ireland). Anticancer Res 37:2753-2760,2017.
Updates and Critical Evaluation on Novel Biomarkers for the Malignant Progression of Intraductal Papillary Mucinous Neoplasms of the Pancreas. D. MORIS, C. DAMASKOS, E. SPARTALIS, A. PAPALAMPROS, S. VERNADAKIS, D. DIMITROULIS, J. GRINIATSOS, E. FELEKOURAS, N. NIKITEAS (Columbus, OH, USA; Athens, Greece; Riyadh, Kingdom of Saudi Arabia). Anticancer Res 37:2185-2194,2017.
Implications of Different Cancer Stem Cell Phenotypes in Breast Cancer. A.D.C. PAULA, C. LOPES (Porto, Portugal). Anticancer Res 37:2173-2183,2017.
The Kynurenine Pathway: A Primary Resistance Mechanism in Patients with Glioblastoma. P.P. SORDILLO, L.A. SORDILLO, L. HELSON (Quakertown, PA; New York, NY, USA). Anticancer Res 37:2159-2171,2017.
Antitumor and Cancer-preventative Function of Fucoxanthin: A Marine Carotenoid. Y. SATOMI (Suzuka, Japan). Anticancer Res 37:1557-1562, 2017.
Acute Graft Versus Host Disease: A Comprehensive Review. S. NASSEREDDINE, H. RAFEI, E. ELBAHESH, I. TABBARA (Washington, DC; Huntsville, AL, USA). Anticancer Res 37:1547-1555, 2017.
Synchronous Endometrial and Ovarian Cancer in Young Women: Case Report and Review of the Literature. A. DOGAN, B. SCHULTHEIS, G.A. REZNICZEK, Z. HILAL, C. CETIN, G. HÄUSLER, C.B. TEMPFER (Bochum, Germany; Mauerbach, Austria). Anticancer Res 37:969-978, 2017.
The role of IL-7 in Immunity and Cancer. J. LIN, Z. ZHU, H. XIAO, M.R. WAKEFIELD, V.A. DING, Q. BAI, Y. FANG (Des Moines, IA; Columbia, MO, USA; Chenzhou, PR China). Anticancer Res 37:963-967, 2017.
Clinical Target Volume in Biliary Carcinoma: A Systematic Review of Pathological Studies. I. MARINELLI, A. GUIDO, L. FUCCIO, A. FARIOLI, V. PANNI, L. GIACCHERINI, A. ARCELLI, G. ERCOLANI, G. BRANDI, S. CAMMELLI, A. GALUPPI, G. MACCHIA, R. FRAKULLI, G.C. MATTIUCCI, F. CELLINI, M. BUWENGE, M. RENZULLI, F. DEODATO, S. CILLA, V. VALENTINI, V. TOMBOLINI, R. GOLFIERI, A.G. MORGANTI (Rome; Bologna; Campobasso, Italy). Anticancer Res 37:955-961, 2017.
Possible Therapeutic Effects of Ozone Mixture on Hypoxia in Tumor Development. M. LUONGO, A.L. BRIGIDA, L. MASCOLO, G. GAUDINO (Naples, Italy). Anticancer Res 37:425-435, 2017.
Italian Prostate Biopsies Group: 2016 Updated Guidelines Insights. A. FANDELLA, V. SCATTONI, A. GALOSI, P. PEPE, M. FIORENTINO, C. GAUDIANO, M. GIAMPAOLI, R. GUNELLI, P. MARTINO, V. MONTANARO, R. MONTIRONI, T. PIERANGELI, A. STABILE, A. BERTACCINI (Treviso; Milan; Ancona; Catania; Bologna; Forlì; Bari; Naples, Italy). Anticancer Res 37:413-424, 2017.
Potential Predictive Role of MicroRNAs in the Neoadjuvant Treatment of Esophageal Cancer. D. VRANA, M. MATZENAUER, R. AUJESKY, R. VRBA, C. NEORAL, B. MELICHAR, P. SOUČEK (Olomouc; Prague, Czech Republic). Anticancer Res 37:403-412, 2017.
The Evolving Role of Local Treatments for HCC in the Third Millennium. P. MAGISTRI, G. TARANTINO, R. BALLARIN, M. BERRETTA, Α. PECCHI, G. RAMACCIATO, F. DI BENEDETTO (Modena; Rome; Aviano, Italy). Anticancer Res 37:389-401, 2017.
Immune-based Therapies for Non-small Cell Lung Cancer. H. RAFEI, E. EL-BAHESH, A. FINIANOS, S. NASSEREDDINE, I. TABBARA (Washington, DC; Huntsville, AL, USA; Jounieh, Lebanon). Anticancer Res 37:377-387, 2017.
Histone Deacetylase Inhibitors: An Attractive Therapeutic Strategy Against Breast Cancer. C. DAMASKOS, S. VALSAMI, M. KONTOS, E. SPARTALIS, T. KALAMPOKAS, E. KALAMPOKAS, A. ATHANASIOU, D. MORIS, A. DASKALOPOULOU, S. DAVAKIS, G. TSOUROUFLIS, K. KONTZOGLOU, D. PERREA, N. NIKITEAS, D. DIMITROULIS (Athens, Greece; Aberdeen, UK; Cleveland, OH, USA). Anticancer Res 37:35-46, 2017.
Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme. J. POLIVKA JR, J. POLIVKA, L. HOLUBEC, T. KUBIKOVA, V. PRIBAN, O. HES, K.  PIVOVARCIKOVA, I. TRESKOVA (Plzen, Czech Republic).  Anticancer Res 37:21-34, 2017.
Three Pathways of Colonic Carcinogenesis in Rats. C.A. RUBIO (Stockholm, Sweden).  Anticancer Res 37:15-20, 2017.
Parenchymal-sparing Hepatectomy as the New Doctrine in the Treatment of Liver-metastatic Colorectal Disease: Beyond Oncological Outcomes. D. MORIS, D. DIMITROULIS, S. VERNADAKIS, A. PAPALAMPROS, E. SPARTALIS, A. PETROU, T.M. PAWLIK, E.  FELEKOURAS (Cleveland; Columbus, OH, USA; Athens, Greece). Anticancer Res 37:9-14, 2017.
Clinical Implications of High-mobility Group Box-1 (HMGB1) and the Receptor for Advanced Glycation End-products (RAGE) in Cutaneous Malignancy: A Systematic Review. A.H. NGUYEN, S.Q. DETTY, D.K. AGRAWAL (Omaha, NE, USA). Anticancer Res 37:1-8, 2017.
Vitamin D and Myofibroblasts in Fibrosis and Cancer: At Cross-purposes with TGF-β/SMAD Signaling. S. SHANY, I. SIGAL-BATIKOFF, S. LAMPRECHT (Beersheva, Israel). Anticancer Res 36:6225-6234, 2016.
Lung Adenocarcinoma in Never Smokers: Problems of Primary Prevention from Aspects of Susceptible Genes and Carcinogens. I. OKAZAKI, S. ISHIKAWA, W. ANDO, Y. SOHARA (Tokyo; Nasushiobara; Okegawa, Japan). Anticancer Res 36:6207-6224, 2016.
Radium-223: Insight and Perspectives in Bone-metastatic Castration-resistant Prostate Cancer. F.E. BURONI, M.G. PERSICO, F. PASI, L. LODOLA, R. NANO, C. APRILE (Pavia, Italy). Anticancer Res 36:5719-5730, 2016.
Potential Anti-metastasis Natural Compounds for Lung Cancer. P. CHANVORACHOTE, S. CHAMNI, C. NINSONTIA, P.P. PHIBOONCHAIYANAN (Bangkok, Thailand).  Anticancer Res 36:5707-5717, 2016.
The Anticancer Activity of the Old Neuroleptic Phenothiazine-type Drug Thioridazine. G. SPENGLER, Á. CSONKA, J. MOLNÁR, L. AMARAL (Szeged, Hungary; Lisbon, Portugal). Anticancer Res 36:5701-5706, 2016.
Heart Peptide Hormones: Adjunct and Primary Treatments of Cancer. D.L. VESELY (Tampa, FL, USA). Anticancer Res 36:5693-5700, 2016.
Targeting Cellular Signaling Pathways in Breast Cancer Stem Cells and its Implication for Cancer Treatment. B.R.B. PIRES, Í.S.S. DE AMORIM, L.D.E. SOUZA, J.A. RODRIGUES, A.L. MENCALHA (Rio de Janeiro, RJ, Brazil).  Anticancer Res 36:5681-5691, 2016.
Regulation of the Expression of Cytoplasmic Polyadenylation Element Binding Proteins for the Treatment of Cancer. Y. CHEN, Y.-H. TSAI, S.-H. TSENG (New Taipei; Taoyuan; Taipei, Taiwan, ROC).  Anticancer Res 36:5673-5680, 2016.
Identification of Important Compounds Isolated from Natural Sources that Have Activity Against Multidrug-resistant Cancer Cell Lines: Effects on Proliferation, Apoptotic Mechanism and the Efflux Pump Responsible for Multi-resistance Phenotype. L. AMARAL, G. SPENGLER, J. MOLNAR (Szeged, Hungary; Lisbon, Portugal). Anticancer Res 36:5665-5672, 2016.
The Antitumor Effect of Singlet Oxygen. G. BAUER (Freiburg, Germany). Anticancer Res 36:5649-5663, 2016.
Page: 1 2 3 4 5 6 ... 7 8 9 10 11 12 
Custom Tables Plugin 05a1a29bdcae7b12229e651a9fd48b11

IMPORTANT NOTE: You may submit your article only through our online submission system